SARS-CoV-2 delta variant neutralisation after heterologous ChAdOx1-S/BNT162b2 vaccination

被引：20
|
作者：
Behrens, Georg M. N. [1 ,2 ]
Cossmann, Anne [1 ]
Stankov, Metodi V. [1 ]
Nehlmeier, Inga [3 ]
Kempf, Amy [3 ]
Hoffmann, Markus [3 ,4 ]
Poehlmann, Stefan [3 ,4 ]
机构：
[1] Hannover Med Sch, Dept Rheumatol & Immunol, D-30625 Hannover, Germany
[2] German Ctr Infect Res, Partner Site Hannover Braunschweig, Hannover, Germany
[3] Leibniz Inst Primate Res, Infect Biol Unit, German Primate Ctr, Gottingen, Germany
[4] Georg August Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany
来源：
LANCET | 2021年 / 398卷 / 10305期
关键词：
D O I：
10.1016/S0140-6736(21)01891-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1041 / 1042
页数：3
相关论文
共 50 条
  • [1] Immunogenic dynamics and SARS-CoV-2 variant neutralisation of the heterologous ChAdOx1-S/BNT162b2 vaccination: Secondary analysis of the randomised CombiVacS study
    Garcia-Perez, Javier
    Gonzalez-Perez, Maria
    Castillo de la Osa, Maria
    Borobia, Alberto M.
    Castano, Luis
    Jesus Bertran, Maria
    Campins, Magdalena
    Portoles, Antonio
    Lara, Davis
    Bermejo, Mercedes
    Conde, Patricia
    Hernandez-Gutierrez, Lourdes
    Carcas, Antonio
    Arana-Arri, Eunate
    Tortajada, Marta
    Fuentes, Inmaculada
    Ascaso, Ana
    Teresa Garcia-Morales, Maria
    Erick de la Torre-Tarazona, Humberto
    Arribas, Jose-Ramon
    Imaz-Ayo, Natale
    Mellado-Pau, Eugenia
    Agusti, Antonia
    Perez-Ingidua, Carla
    Gomez de la Camara, Agustin
    Ochando, Jordi
    Belda-Iniesta, Cristobal
    Frias, Jesus
    Alcami, Jose
    Perez-Olmeda, Mayte
    ECLINICALMEDICINE, 2022, 50
  • [2] Increased neutralization of SARS-CoV-2 Delta variant after heterologous ChAdOx1 nCoV-19/BNT162b2 versus homologous BNT162b2 vaccination
    Bauswein, Markus
    Peterhoff, David
    Plentz, Annelie
    Hiergeist, Andreas
    Wagner, Ralf
    Gessner, Andre
    Salzberger, Bernd
    Schmidt, Barbara
    Bauernfeind, Stilla
    ISCIENCE, 2022, 25 (02)
  • [3] Evaluation of Two-Month Antibody Levels after Heterologous ChAdOx1-S/BNT162b2 Vaccination Compared to Homologous ChAdOx1-S or BNT162b2 Vaccination
    Barocci, Simone
    Orlandi, Chiara
    Diotallevi, Aurora
    Buffi, Gloria
    Ceccarelli, Marcello
    Vandini, Daniela
    Carlotti, Eugenio
    Galluzzi, Luca
    Rocchi, Marco Bruno Luigi
    Magnani, Mauro
    Casabianca, Anna
    VACCINES, 2022, 10 (04)
  • [4] Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
    Hammerschmidt, Swantje I.
    Bosnjak, Berislav
    Bernhardt, Guenter
    Friedrichsen, Michaela
    Ravens, Inga
    Dopfer-Jablonka, Alexandra
    Hoffmann, Markus
    Pohlmann, Stefan
    Behrens, Georg M. N.
    Foerster, Reinhold
    CELLULAR & MOLECULAR IMMUNOLOGY, 2021, 18 (10) : 2455 - 2456
  • [5] Neutralization of the SARS-CoV-2 Delta variant after heterologous and homologous BNT162b2 or ChAdOx1 nCoV-19 vaccination
    Swantje I. Hammerschmidt
    Berislav Bosnjak
    Günter Bernhardt
    Michaela Friedrichsen
    Inga Ravens
    Alexandra Dopfer-Jablonka
    Markus Hoffmann
    Stefan Pöhlmann
    Georg M. N. Behrens
    Reinhold Förster
    Cellular & Molecular Immunology, 2021, 18 : 2455 - 2456
  • [6] Heterologous ChAdOx1-S/BNT162b2 Vaccination: Neutralizing Antibody Response to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
    Dimeglio, Chloe
    Herin, Fabrice
    Da-Silva, Isabelle
    Jougla, Isabelle
    Pradere, Claire
    Porcheron, Marion
    Martin-Blondel, Guillaume
    Chapuy-Regaud, Sabine
    Izopet, Jacques
    CLINICAL INFECTIOUS DISEASES, 2022, 74 (07) : 1315 - 1316
  • [7] Immunogenicity of a third dose with mRNA-vaccines in the ChAdOx1-S/BNT162b2 vaccination SARS-CoV-2 variants
    Garcia-Perez, Javier
    Borobia, Alberto M.
    Perez-Olmeda, Mayte
    Portoles, Antonio
    Castano, Luis
    Campins-Arti, Magdalena
    Bertran, Maria Jesus
    Bermejo, Mercedes
    Arribas, Jose Ramon
    Lopez, Andrea
    Ascaso-del-Rio, Ana
    Arana-Arri, Eunate
    Camps, Inmaculada Fuentes
    Vilella, Anna
    Cascajero, Almudena
    Garcia-Morales, Maria Teresa
    de la Osa, Maria Castillo
    Ingidua, Carla Perez
    Lora, David
    Jimenez-Santana, Paloma
    Pino-Rosa, Silvia
    de la Camara, Agustin Gomez
    de la Torre-tarazona, Erick
    Calonge, Esther
    Cruces, Raquel
    Belda-Iniesta, Cristo bal
    Alcami, Jose
    Frias, Jesus
    Carcas, Antonio J.
    Diez-Fuertes, Francisco
    ISCIENCE, 2024, 27 (09)
  • [8] Heterologous ChAdOx1 and Bnt162b2 vaccination induces strong neutralizing antibody responses against SARS-CoV-2 including delta variant with tolerable reactogenicity
    Bae, Seongman
    Ko, Jae-Hoon
    Choi, Ju-Yeon
    Park, Woo-Jung
    Lim, So Yun
    Ahn, Jin Young
    Song, Kyoung-Ho
    Lee, Kyoung Hwa
    Song, Young Goo
    Kim, Yong Chan
    Park, Yoon Soo
    Choi, Won Suk
    Jeong, Hye Won
    Kim, Shin-Woo
    Kwon, Ki Tae
    Kang, Eun-Suk
    Kim, Ah-Ra
    Jang, Sundong
    Kim, Byoungguk
    Kim, Sung Soon
    Jang, Hee-Chang
    Choi, Jun Yong
    Kim, Sung-Han
    Peck, Kyong Ran
    CLINICAL MICROBIOLOGY AND INFECTION, 2022, 28 (10) : 1390.e1 - 1390.e7
  • [9] Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
    Matan Levine-Tiefenbrun
    Idan Yelin
    Hillel Alapi
    Rachel Katz
    Esma Herzel
    Jacob Kuint
    Gabriel Chodick
    Sivan Gazit
    Tal Patalon
    Roy Kishony
    Nature Medicine, 2021, 27 : 2108 - 2110
  • [10] Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
    Levine-Tiefenbrun, Matan
    Yelin, Idan
    Alapi, Hillel
    Katz, Rachel
    Herzel, Esma
    Kuint, Jacob
    Chodick, Gabriel
    Gazit, Sivan
    Patalon, Tal
    Kishony, Roy
    NATURE MEDICINE, 2021, 27 (12) : 2108 - +
12345